{"title":"The use of the Gianturco intravascular stent in stenotic hemodialysis fistulas.","authors":"G A Beathard","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This study was initiated to investigate the use of the Gianturco intravascular stent in prolonging dialysis access graft patency after angioplasty. Stents were placed in 25 patients with follow-up to date of 0.5-8 months. The stent used was 1.5 x 3 cm and consisted of two units connected by a single strut. In Phase 1, the strut was rigid, and the stent had no barbs. The rigidity of the stent and stent migration caused problems. In Phase 2, an articulated strut design was used, and in Phase 3, barbs were added. These modifications solved the previously noted problems. No anticoagulation was used, and clotting was not a significant problem. The duration of patency for the total group was not significantly better than for control groups. However, there were no losses with the modified stent design used in Phases 2 and 3 with follow-up to date of 0.5-5.5 months. Further study of this treatment modality appears warranted.</p>","PeriodicalId":77493,"journal":{"name":"ASAIO transactions","volume":"37 3","pages":"M234-5"},"PeriodicalIF":0.0000,"publicationDate":"1991-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASAIO transactions","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This study was initiated to investigate the use of the Gianturco intravascular stent in prolonging dialysis access graft patency after angioplasty. Stents were placed in 25 patients with follow-up to date of 0.5-8 months. The stent used was 1.5 x 3 cm and consisted of two units connected by a single strut. In Phase 1, the strut was rigid, and the stent had no barbs. The rigidity of the stent and stent migration caused problems. In Phase 2, an articulated strut design was used, and in Phase 3, barbs were added. These modifications solved the previously noted problems. No anticoagulation was used, and clotting was not a significant problem. The duration of patency for the total group was not significantly better than for control groups. However, there were no losses with the modified stent design used in Phases 2 and 3 with follow-up to date of 0.5-5.5 months. Further study of this treatment modality appears warranted.
本研究旨在探讨Gianturco血管内支架在延长血管成形术后透析通路移植物通畅中的应用。25例患者放置支架,随访0.5 ~ 8个月。所使用的支架尺寸为1.5 x 3cm,由两个单元组成,由单个支柱连接。在第一阶段,支架是刚性的,支架没有倒刺。支架的刚性和支架的迁移造成了问题。在第二阶段,采用了铰接式支撑设计,在第三阶段,增加了倒钩。这些修改解决了之前注意到的问题。没有使用抗凝剂,凝血也不是什么大问题。总组的通畅时间不明显优于对照组。然而,在第2期和第3期使用改良的支架设计,随访时间为0.5-5.5个月,没有损失。对这种治疗方式的进一步研究似乎是必要的。